Bioactivation of isoxazole-containing bromodomain and extra-terminal domain (BET) inhibitors

Authors

Noah R Flynn, Washington University School of Medicine in St. Louis
Michael D Ward, Washington University School of Medicine in St. Louis
Mary A Schleiff, University of Arkansas for Medical Sciences
Corentine M C Laurin, University of Oxford
Rohit Farmer, Washington University School of Medicine in St. Louis
Stuart J Conway, University of Oxford
Gunnar Boysen, University of Arkansas for Medical Sciences
S Joshua Swamidass, Washington University School of Medicine in St. Louis
Grover P Miller, University of Arkansas for Medical Sciences

Journal

Metabolites

Publication Date

2021

Volume

11

Issue

6

First Page

390

Document Type

Open Access Publication

DOI

10.3390/metabo11060390

Rights and Permissions

Flynn NR, Ward MD, Schleiff MA, et al. Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors. Metabolites. 2021;11(6):390. Published 2021 Jun 15. doi:10.3390/metabo11060390

Recommended Citation

Flynn, Noah R; Ward, Michael D; Schleiff, Mary A; Laurin, Corentine M C; Farmer, Rohit; Conway, Stuart J; Boysen, Gunnar; Swamidass, S Joshua; and Miller, Grover P, "Bioactivation of isoxazole-containing bromodomain and extra-terminal domain (BET) inhibitors." Metabolites. 11, 6. 390 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10493